Verity Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Verity Asset Management's BMY Position: Q3 2026 in Review
Verity Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.61% in Q3 2026, buying an estimated $12K and bringing the position to 31,594 shares worth $1.97M. The position accounts for 0.76% of the portfolio, ranked #38.
Verity Asset Management first reported a position in BMY in Q3 2016 and has held it in 19 quarters since. The position peaked at $2.27M in Q1 2025. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Verity Asset Management held 31,594 shares of Bristol-Myers Squibb worth $1.97M as of Q3 2026.
- Verity Asset Management bought 190 Bristol-Myers Squibb shares in Q3 2026, an estimated $12K.
- Bristol-Myers Squibb made up 0.76% of Verity Asset Management's portfolio in Q3 2026, its #38 holding.
- Verity Asset Management first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 19 quarters since.
- Verity Asset Management's Bristol-Myers Squibb position peaked at $2.27M in Q1 2025.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Verity Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.